ProQR Therapeutics logo

ProQR Therapeutics

PRQR | NASDAQ
Chart Builder DCF Calculator
$1.18
-$0.23 (-16.31%)
At close: Nov 16, 2026, 4:00 PM ET
$1.23
+$0.05 (+4.24%)
After-hours: Nov 16, 2026, 7:30 PM ET
-16.31%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
39.2
+4.0 pts
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #549/1021 (Top 54%)

Key Statistics

Market Data

Market Cap $166.52M
1D Range
1.18 1.43
52W Range
1.18 2.45

Valuation (TTM)

PE -2.53
PB 1.84
EV/EBITDA -1.11

Valuation (NTM)

Forward PE N/A
Forward PEG 1.79
Price Target $3.00
Loading financial charts...

Profile

ProQR Therapeutics N.V. operates as a biopharmaceutical enterprise dedicated to discovering and developing RNA-based therapies designed to address genetic disorders. The company's pipeline includes tw...

Sector Healthcare
Industry Biotechnology
Employees 166
IPO Date Sep 18, 2014
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 12, 2026
EPS
-$0.1
Beat +11.17%
REV
$5.84M
Beat +35.77%
Next Earnings
Mar 18, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
4
Consensus
Buy
Price Target
$3.00
Upside
+154.24%
Buy (4)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.